(AESLA) Solagran to open first Bioeffectives facility in Tomsk

Ralph Wragg Australian Business News

Copyright 2008 RWE AUSTRALIAN BUSINESS NEWS PTY LTD. All Rights Reserved.

Sydney - Thursday - March 13: (RWE Aust Business News) - Solagran (ASX:SLA) has finalised a co-operation agreement with the Tomsk regional government in Russia with the first commercial Bioeffectives production facility to be opened on March 20.

Tomsk is a scientific and research hub and home to eight universities.

The agreement with the Tomsk government, to be signed next week, provides for co-oerating in a range of activities in the biotechnology sector.

The facility contains both liquid carbon dioxide and organic solvent extraction processes and the world's first commercial polyprenols production line.

The active ingredient in Solagran's Bioeffective R is Ropren, a specific combination of polyprenols.

Дата: 15.03.2008